http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_139d5793abc20346ea2c92583f43a4de
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Caux |
| name | Christophe Caux |
| given-name | Christophe |
| organization-name | Authors' Affiliations: 1Université de Lyon; 2Université Lyon 1, ISPB; 3INSERM U1052, Centre de Recherche en Cancérologie de Lyon; 4CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon; 5LabEx DEVweCAN; 6Centre Léon Bérard, Lyon, France; and 7Institut Universitaire de France, Paris, France; Authors' Affiliations: 1Université de Lyon; 2Université Lyon 1, ISPB; 3INSERM U1052, Centre de Recherche en Cancérologie de Lyon; 4CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon; 5LabEx DEVweCAN; 6Centre Léon Bérard, Lyon, France; and 7Institut Universitaire de France, Paris, France; Authors' Affiliations: 1Université de Lyon; 2Université Lyon 1, ISPB; 3INSERM U1052, Centre de Recherche en Cancérologie de Lyon; 4CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon; 5LabEx DEVweCAN; 6Centre Léon Bérard, Lyon, France; and 7Institut Universitaire de France, Paris, France; Authors' Affiliations: 1Université de Lyon; 2Université Lyon 1, ISPB; 3INSERM U1052, Centre de Recherche en Cancérologie de Lyon; 4CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon; 5LabEx DEVweCAN; 6Centre Léon Bérard, Lyon, France; and 7Institut Universitaire de France, Paris, France; Authors' Affiliations: 1Université de Lyon; 2Université Lyon 1, ISPB; 3INSERM U1052, Centre de Recherche en Cancérologie de Lyon; 4CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon; 5LabEx DEVweCAN; 6Centre Léon Bérard, Lyon, France; and 7Institut Universitaire de France, Paris, France; Authors' Affiliations: 1Université de Lyon; 2Université Lyon 1, ISPB; 3INSERM U1052, Centre de Recherche en Cancérologie de Lyon; 4CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon; 5LabEx DEVweCAN; 6Centre Léon Bérard, Lyon, France; and 7Institut Universitaire de France, Paris, France 5Université Lyon 1, Lyon, France.; 6INSERM U1052/CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France.; 7Centre Léon Bérard, Lyon, France. Cancer Research Center of Lyon, INSERM UMR 1052, CNRS UMR 5286, Centre Léon Berard, Lyon, France **Centre de recherche en cancérologie, Unité Mixte de Recherche, Inserm 1052, Centre National de la Recherche Scientifique 5286, Centre Léon Bérard, Lyon 69008, France Authors' Affiliations: 1Team 11, Cancer Research Center of Lyon, INSERM; 2Université Lyon, ISPB; 3Centre Léon Bérard; 4Centre Léon Bérard, BioPathology Department; 5Centre Léon Bérard, Medical Oncology Department; 6Centre Léon Bérard, Biostatistic Department, Lyon, France; and 7Inserm U891 Institut Paoli Calmettes Marseille, France; Authors' Affiliations: 1Team 11, Cancer Research Center of Lyon, INSERM; 2Université Lyon, ISPB; 3Centre Léon Bérard; 4Centre Léon Bérard, BioPathology Department; 5Centre Léon Bérard, Medical Oncology Department; 6Centre Léon Bérard, Biostatistic Department, Lyon, France; and 7Inserm U891 Institut Paoli Calmettes Marseille, France; Authors' Affiliations: 1Team 11, Cancer Research Center of Lyon, INSERM; 2Université Lyon, ISPB; 3Centre Léon Bérard; 4Centre Léon Bérard, BioPathology Department; 5Centre Léon Bérard, Medical Oncology Department; 6Centre Léon Bérard, Biostatistic Department, Lyon, France; and 7Inserm U891 Institut Paoli Calmettes Marseille, France Authors' Affiliations: 1Université de Lyon, Lyon, France; 2Université Lyon 1, ISPB; 3Cancer Research Cancer of Lyon, INSERM U1052-CNRS UMR5286; 4Centre Léon Bérard; 5INSERM, U851; 6Université Lyon1, UMS3444/US8; and 7LabEx DEVweCAN, Lyon, France; and 8Merck Serono International SA, Geneva, Switzerland; Authors' Affiliations: 1Université de Lyon, Lyon, France; 2Université Lyon 1, ISPB; 3Cancer Research Cancer of Lyon, INSERM U1052-CNRS UMR5286; 4Centre Léon Bérard; 5INSERM, U851; 6Université Lyon1, UMS3444/US8; and 7LabEx DEVweCAN, Lyon, France; and 8Merck Serono International SA, Geneva, Switzerland; Authors' Affiliations: 1Université de Lyon, Lyon, France; 2Université Lyon 1, ISPB; 3Cancer Research Cancer of Lyon, INSERM U1052-CNRS UMR5286; 4Centre Léon Bérard; 5INSERM, U851; 6Université Lyon1, UMS3444/US8; and 7LabEx DEVweCAN, Lyon, France; and 8Merck Serono International SA, Geneva, Switzerland; Authors' Affiliations: 1Université de Lyon, Lyon, France; 2Université Lyon 1, ISPB; 3Cancer Research Cancer of Lyon, INSERM U1052-CNRS UMR5286; 4Centre Léon Bérard; 5INSERM, U851; 6Université Lyon1, UMS3444/US8; and 7LabEx DEVweCAN, Lyon, France; and 8Merck Serono International SA, Geneva, Switzerland; Authors' Affiliations: 1Université de Lyon, Lyon, France; 2Université Lyon 1, ISPB; 3Cancer Research Cancer of Lyon, INSERM U1052-CNRS UMR5286; 4Centre Léon Bérard; 5INSERM, U851; 6Université Lyon1, UMS3444/US8; and 7LabEx DEVweCAN, Lyon, France; and 8Merck Serono International SA, Geneva, Switzerland Authors' Affiliations: 1Centre de Recherche en Cancérologie de Lyon, UMR INSERM U1052 CNRS 5286, Centre Léon Bérard, Université de Lyon, Lyon, France; and 2Division of Oncology, Stanford University, Department of Medicine, Stanford, California From the *Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom; ‡Schering-Plough Laboratory for Immunological Research, Dardilly 69571, France; §Molecular Medicine Research Institute, Mountain View, California 94043; and ‖The DNAX Research Institute, Palo Alto, California 94304 From Schering-Plough, Laboratory for Immunological Research, Dardilly, France and the Basel Institute for Immunology, Basel, Switzerland. Laboratory for Immunological Research, Schering-Plough Research Institute, Dardilly, France Schering-Plough, Laboratory for Immunological Research, Dardilly, France Univ Lyon, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France Authors' Affiliations: 1Centre Léon Bérard; 2Université Lyon 1; and 3Institut National de la Sant6 et de la Recherche Mddicale U1052, Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France; Authors' Affiliations: 1Centre Léon Bérard; 2Université Lyon 1; and 3Institut National de la Sant6 et de la Recherche Mddicale U1052, Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France; Authors' Affiliations: 1Centre Léon Bérard; 2Université Lyon 1; and 3Institut National de la Sant6 et de la Recherche Mddicale U1052, Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France Immunology Virology and Inflammation Department, INSERM U1052, CNRS 5286 Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France. Université de Lyon, Lyon, France;; Université Lyon 1, Institut des Sciences Pharmaceutiques et Biolgiques, Lyon, France;; Inserm U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France;; Centre National de la Recherche Scientifique Unité Mixte de Recherche 5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France;; LabEx DEVweCAN, Lyon, France; aLaboratory for Immunological Research, Schering-Plough, 69571 Dardilly, France †Equipe Cytokines et Cancer, Institut National de la Santé et de la Recherche Médicale Unité 590, Centre Léon Bérard; From the *Schering-Plough, Laboratory for Immunological Research, 69571, Dardilly, France; and ‡DNAX, Research Institute, Palo Alto, California 94304 Cancer Research Center of Lyon INSERM U1052 and CNRS UMR5286 Lyon France; Centre Léon Bérard Lyon France Centre Léon Bérard, Cancer Research Center of Lyon (CRCL), Univ Lyon, Université Claude Bernard Lyon 1, Lyon France; Immunology Virology Inflammation (IVI) department, Team “Therapeutic targeting of the tumor cells and their immune stroma”, Lyon, France INSERM 1052, CNRS 5286, Department of Translational Research and Innovation, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, CRCL, Université Claude Bernard Lyon 1, Lyon, France Laboratory for Immunological Research, Schering-Plough Research Institute , Dardilly, France †Schering-Plough, Laboratory for Immunological Research, Dardilly, France Université Claude Bernard Lyon 1, Centre Leon Berard, Lyon, Rhone-Alpes, France 1INSERM, U590;; 2Centre Léon Bérard, Equipe Cytokines et Cancers;; 3Université Lyon 1, ISPB;; 4IFR62; 1Schering-Plough, Laboratory for Immunological Research, 69571 Dardilly, France §Institut des Sciences Pharmaceutiques et Biologiques, Université Lyon 1, Université de Lyon, 69373 Lyon, France;; ¶Centre National de la Recherche Scientifique, Unite Mixte de Recherche 5286, Département Immunité, Virus et Microenvironnement, Centre de Recherche en Cancérologie de Lyon, 69373 Lyon, France;; ‖INSERM U1052, Centre Léon Bérard, 69373 Lyon, France;; #LabEx DEVweCAN, 69373 Lyon, France; ††Schering-Plough Laboratory for Immunological Research, Dardilly, France; and UCBL1,Centre Leon Berard UMR Inserm 1052/CNRS 5286, Lyon, Rhone-Alpes, France §INSERM, U590, Lyon F-69008, France From Schering-Plough, Laboratory for Immunological Research, Dardilly, France From the Schering-Plough Research Institute, Laboratory for Immunological Research, Dardilly, France. From the *Institut National de la Santé et de la Recherche Médicale U 404 “Immunité et Vaccination,” Lyon, France; ‡Centre National de la Recherche Scientifique Unité de Recherche Associée 602, Lyon, France; §Schering-Plough Laboratory for Immunological Research, Dardilly, France; and ‖Baylor Institute of Immunology Research, Dallas, Texas 75246 Laboratory for Immunological Research, Schering Plough, Dardilly, France *Schering Plough, Laboratory for Immunological Research, Dardilly, France; and 1Innovation in Immuno-monitoring and Immunotherapy Platform (PI3), Léon Bérard Cancer Center, Lyon, France.; 2Team 11, INSERM U1052/CNRS 5286, Cancer Research Center of Lyon, Lyon, France.; 3Université de Lyon, Lyon, France. *Schering-Plough Laboratory for Immunological Research, Dardilly, France; and; <. > 1Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.; 2Team 11, Immunology Virology Inflammation (IVI) Department, INSERM U-1052, Cancer Research Center of Lyon, Lyon, France.; 3Innovation and Translational Research Department, Centre Léon Bérard, Lyon, France. Schering-Plough, Laboratory for Immunological Research , Dardilly, France Laboratory for Immunological Research, Schering- Plough Inserm UMR‐S1052, Centre de Recherche en Cancérologie de Lyon Lyon France; CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon Lyon France; UNIV UMR1052, Centre de Recherche en Cancérologie de Lyon Lyon France; Université de Lyon Lyon France; Centre Léon Bérard Lyon France Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, INSERM 1052, CNRS 5286, 69008 Lyon, France;; University of Lyon, Université Claude Bernard Lyon 1, 69008 Lyon, France; From the Laboratory for Immunological Research, Schering-Plough, Dardilly, France; and Institut National de la Santé et de la Recherche Médicale (INSERM) U346, Hôpital E. Herriot, Pavillon R, Lyon, France. From INSERM U404, Immunité et Vaccination, Lyon, France; Unité d'Immunologie Virale, Institut Pasteur, Paris, France; INSERM U255, Institut Curie, Paris, France; and Schering Plough, Laboratory for Immunological Research, Dardilly, France. INSERM 1052 CNRS 5286 Centre Léon Bérard Cancer Research Center of Lyon Univ Lyon Université Claude Bernard Lyon 1 Lyon France Centre Léon Berard, 28 Rue Laennec, 69373 Lyon Cedex 08, France; 4Centre de Recherche en Cancérologie de Lyon, Inserm U1052/CNRS 5286, Lyon, France. Schering‐Plough Laboratory for Immunological Research, Dardilly, France Université de Lyon Lyon France; Université Lyon 1 ISPB Lyon France; INSERM U1052 Centre de Recherche en Cancérologie de Lyon Department of Immunity, Virus, and Microenvironment Lyon France; CNRS UMR5286 Centre de Recherche en Cancérologie de Lyon Department of Immunity, Virus, and Microenvironment Lyon France; LabEx DEVweCAN Lyon France 1Inserm, U590,; 2Centre Léon Bérard, Equipe Cytokines et Cancers,; 3Université Lyon 1, ISPB, and; 4IFR62, Lyon, France Baylor Institute for Immunology Research, Dallas, Texas, 75204;, , ,; Laboratory of Immunological Research, Schering-Plough, Dardilly, 69572, France;, ,; Department of Immunobiology, DNAX Research Institute, Palo Alto, California, 94304; 1Schering-Plough Laboratory for Immunological Research, 69571 Dardilly, France TERI (Tumor Escape, Resistance and Immunity) Department, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Lyon France †Laboratory for Immunological Research, Schering Plough, Dardilly, France; UMR INSERM 1052, Centre Léon Bérard, 28 rue Laennec, 69008 Lyon, France Université Claude Bernard Lyon 1, Centre de recherche en cancérologie de Lyon, Lyon, France; Department of Innovation and Translational Research, Centre Léon Bérard, Lyon, France Schering-Plough, Laboratory for Immunological Research, Dardilly , Lyon, France 1Laboratory for Immunological Research, Schering-Plough, 69571 Dardilly, France From *Schering Plough, Laboratory for Immunological Research, 69571 Dardilly, France; and the ‡Department of Nephrology, Leiden University Hospital, 2333 Leiden, The Netherlands †Laboratory for Immunological Research, Schering-Plough, Dardilly, France CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON INSERM U1052 CNRS 5286 Centre Léon Bérard Centre de Recherche en Cancérologie de Lyon Univ Lyon Université Claude Bernard Lyon 1 Lyon France Authors' Affiliations: Departments of 1Medical Oncology, 2Pathology, 3Surgery, and 4Biostatistics; 5Université Lyon 1, ISPB, INSERM U1052, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, Lyon; and 6Department of Surgery, Infirmerie Protestante, Chemin du Penthod Caluire, Caluire et Cuire, Rhone, France *Laboratory for Immunological Research, Schering-Plough, Dardilly, France;; ‡Centre Léon Bérard, Lyon, France |
Incoming Links
Total number of triples: 219.